Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Debenhams Group 'continues to review' debt facilities

(Sharecast News) - Debenhams Group - the newly rebranded Boohoo - said on Thursday that it continues to review its debt facilities "in the ordinary course of business". Responding to press speculation about a potential new debt facility, it said in a brief statement: "Shareholders are reminded, that as previously announced, it has in place an existing £125m revolving credit facility which does not expire until October 2026."

It added: "Debenhams will provide any further updates as appropriate."

Boohoo bought Debenhams out of administration for £55m in 2021.

The statement came after Sky News reported on Wednesday that Boohoo was close to securing a £175m refinancing boost.

According to Sky, Boohoo is in advanced talks to secure a "significant chunk" of debt from US-based investment firm TPG.

Sky said the parties were close to an agreement, although precise details, including the ultimate size of the refinancing package and the extent of TPG's contribution, were unclear.

If confirmed, it will re-establish TPG as a Debenhams stakeholder more than 20 years after the buyout firm was part of a consortium which delisted it from the London Stock Exchange.

At 1510 BST, Boohoo shares were up 5.6% at 20.37p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.